Sharps Technology (STSS) Cash from Financing Activities (2021 - 2025)
Sharps Technology's (STSS) quarterly Cash from Financing Activities came in at $4.8 million in Q4 2025, up 2297.89% year-on-year from $199461.0 in Q4 2024, and down 97.57% quarter-over-quarter from $196.8 million in Q3 2025.
Sharps Technology (STSS) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Sharps Technology has disclosed Cash from Financing Activities across 5 years of filings, most recently posting $4.8 million for Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $4.8 million, up 2297.89% year-over-year; the trailing twelve-month figure through Dec 2025 was $204.5 million (up 3361.62% YoY), and the FY2025 annual result was $215.5 million, up 3548.13% from the prior year.
- Cash from Financing Activities came in at $4.8 million for Q4 2025 at Sharps Technology, down from $196.8 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $196.8 million in Q3 2025 to a low of $396.0 in Q1 2024.
- The 5-year median for Cash from Financing Activities is $2.8 million (2021), against an average of $16.6 million.
- Across the five-year window, Cash from Financing Activities surged 9865.26% in 2023 and plunged 99.99% in 2024, its largest moves.
- Sharps Technology's Cash from Financing Activities stood at $2.8 million in 2021, then jumped by 339.91% to $12.2 million in 2022, then plunged by 60.74% to $4.8 million in 2023, then slumped by 95.84% to $199461.0 in 2024, then jumped by 2297.89% to $4.8 million in 2025.
- The last three Cash from Financing Activities figures came in at $4.8 million (Q4 2025), $196.8 million (Q3 2025), and $199461.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Sharps Technology | - | - | 1.79 Mn | 4.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.78 Mn |
| Dec 31, 2025 | 4.78 Mn |
| Sep 30, 2025 | 196.77 Mn |
| Sep 30, 2025 | 196.77 Mn |
| Dec 31, 2024 | 199,461.00 |
| Dec 31, 2024 | 199,461.00 |
| Sep 30, 2024 | 2.74 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Jun 30, 2024 | 2.97 Mn |
| Mar 31, 2024 | 396.00 |
| Mar 31, 2024 | 396.00 |
| Sep 30, 2023 | 4.79 Mn |
| Sep 30, 2023 | 4.79 Mn |
| Mar 31, 2023 | 3.24 Mn |
| Mar 31, 2023 | 3.24 Mn |
| Jun 30, 2022 | 12.20 Mn |
| Jun 30, 2022 | 12.20 Mn |
| Mar 31, 2022 | 32,500.00 |
| Mar 31, 2022 | 32,500.00 |